Industry News
Australian biotech market watch 16/10/09
Biota, Primary Health Care, ResMed, Acrux, Ansell [ + ]
Adelaide to host AusBiotech 2011
Annual biotechnology conference to be held in the festival state. [ + ]
Lifting the lid on the epigenome
Salk researchers map the first complete human epigenome. [ + ]
Australian biotech market watch 14/10/09
Sirtex, QRxPharma, Biota, Ramsay Health Care, ResMed, CSL [ + ]
Feature: Multiplexing cancers of unknown primaries
A new test under development could aid in the currently problematic diagnosis of cancers of unknown primary. [ + ]
Gene linked to anaemia found
Common gene variant found to regulate iron and haemoglobin levels. [ + ]
Australian biotech market watch 09/10/09
CSL, Primary Health Care, Cochlear, Blackmores, Ansell [ + ]
Revealing the dark matter of the genome
New map of copy number variation in the human genome could help reveal missing genetic variants for common disease. [ + ]
Aussie bacterium a true gold digger
Bacterium found to catalyse the biomineralisation of gold. Could lead to new biosensors. [ + ]
Feature: Closing the gap
A groundbreaking clinical trial is underway in the Northern Territory that could help prevent an all-too-common disease and change the way vaccinations are delivered to children. [ + ]
Australian biotech market watch 07/10/09
Ramsay, Cochlear, pSivida, Ansell, Biota [ + ]
Sigma-Aldrich partners with ThalesNano
Sigma-Aldrich has partnered with flow chemistry company ThalesNano to provide global access to next-generation flow chemistry CatCart catalyst products.
[ + ]IBM aims for personalised medicine with DNA chip
IBM's research effort proposes to map genetic code in minutes at a cost of between US$100 and US$1,000. [ + ]
Elizabeth Blackburn nabs Nobel in medicine
First Australian women and 11th Australian to receive a Nobel Prize. [ + ]
Australian biotech market watch 02/10/09
Biota, Ramsay, Cochlear, Blackmores, Clinuvel [ + ]